Showing results (11-20 of 21) with videos related to

Sort By:
Pageof 3
Journal of Translational Medicine|October 11, 2022
CSPG4 expression in soft tissue sarcomas is associated with poor prognosis and low cytotoxic immune responseLaurys Boudin, A de Nonneville, Pascal Finetti, et al.
International Journal of Radiation Oncology, Biology, Physics|September 28, 2025
The Role of External Beam Radiation Therapy in Thyroid Cancer Management: A Scoping ReviewArnaud Beddok, Jean-Baptiste Morvan, Laurys Boudin, et al.
Oncoimmunology|June 9, 2021
Immune landscape of inflammatory breast cancer suggests vulnerability to immune checkpoint inhibitorsFrançois Bertucci, Laurys Boudin, Pascal Finetti, et al.
Military Medicine|November 2, 2020
Role of Cancer Surgery in the Improvement of the Operative Skills of Military Surgeons During Deployment: A Single-Center StudyLaurys Boudin, Henri de Lesquen, Matthieu Patient, et al.
Cancer Medicine|October 6, 2020
Evaluation of medical practices in oncology in the context of the COVID-19 pandemic in France: Physicians' point of view: the PRATICOVID studyCarole Helissey, Anatole Cessot, Laurys Boudin, et al.
Bulletin Du Cancer|April 16, 2021
How did we take care of our older cancer patients during the first COVID-19 wave? The French experienceCarole Helissey, Djamel Ghebriou, Anatole Cessot, et al.
Cancers|February 25, 2022
Identification of Atypical Circulating Tumor Cells with Prognostic Value in Metastatic Breast Cancer PatientsAlexia Lopresti, Claire Acquaviva, Laurys Boudin, et al.
European Journal of Cancer (Oxford, England : 1990)|February 27, 2016
Immunohistochemical subtypes predict survival in metastatic breast cancer receiving high-dose chemotherapy with autologous haematopoietic stem cell transplantationLaurys Boudin, Christian Chabannon, Patrick Sfumato, et al.
Journal of Cancer|November 24, 2016
Prognostic impact of hormone receptor- and HER2-defined subtypes in inflammatory breast cancer treated with high-dose chemotherapy: a retrospective studyLaurys Boudin, Anthony Gonçalves, Patrick Sfumato, et al.
Bulletin Du Cancer|February 19, 2017
[Impact of Her2 and BRCA1/2 status in high-dose chemotherapy and autologous stem cells transplantation in the treatment of breast cancer: The Institut Paoli Calmettes' experience]Laurys Boudin, Christian Chabannon, Patrick Sfumato, et al.
Pageof 3